Chordia Therapeutics

Japan
Fujisawa, Kanagawa, Japan

Company profile

Chordia Therapeutics company profile

Chordia Therapeutics is a research and development type bioventure specializing in oncology field. The company has a mission of delivering new therapeutic drugs to patients as soon as possible in the area of ​​cancer with high unmet medical need.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-10-12

Headquarters

Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$37.7M
Last funding
Series B / $26.9M / 2019-04-01
Last equity funding
Series B / $26.9M
Investors
8
Lead investors
3
Founders
3
Articles
6

Founders and investors

Founders

Daisuke MorishitaHiroshi MiyakeYasuyoshi Arikawa

Lead investors

JAFCOKyoto University Innovation CapitalTakeda

Investors

Kyoto University Innovation CapitalMitsubishi UFJ CapitalSMBC Venture CapitalSumitomo Mitsui Banking CorporationTakeda